Skip to content

Artiva Biotherapeutics, Inc. ARTV Balance Sheet Statement

FY'25FY'24FY'23
$27.16M-32.9%$40.49M-24.7%$53.76M-47.7%
$81.31M-44.0%$145.19M+519%$23.47M
$112.67M-40.3%$188.63M+136%$79.82M
$6.62M+3.9%$6.37M-21.3%$8.1M
$130.94M-37.5%$209.58M+99.4%$105.11M
$4.45M+11.1%$4.01M
$44K-63.9%$122K
$13.09M+6.8%$12.25M+0.2%$12.23M
$20.97M-8.6%$22.94M-54.8%$50.72M
3K0.0%3K
-$330.55M-34.0%-$246.68M-36.1%-$181.31M
$109.97M-41.1%$186.64M+215%-$162.02M-15.2%
$130.94M-37.5%$209.58M+99.4%$105.11M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Artiva Biotherapeutics, Inc.'s total assets?
Artiva Biotherapeutics, Inc. (ARTV) holds $106.0M in total assets, down 44.6% year over year.
How much debt does Artiva Biotherapeutics, Inc. have?
Artiva Biotherapeutics, Inc. carries $10.3M in total debt against $87.8M of shareholders' equity, a debt-to-equity ratio of 0.12.
How much cash does Artiva Biotherapeutics, Inc. have?
Artiva Biotherapeutics, Inc. holds $21.4M in cash and equivalents.
Can Artiva Biotherapeutics, Inc. cover its short-term obligations?
Its current ratio is 8.16 — current assets exceed current liabilities.
Where does Artiva Biotherapeutics, Inc.'s balance sheet data come from?
Every line is extracted from Artiva Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.